Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1167]
News [3226]
Articles [143]
Editorials [5]
Conferences [143]
elearning [16]
Assessment of cervical and breast cancer screening in Latin America and...
Dr Isabel Mosquera - International Agency for Research on Cancer, Lyon, France
Assessment of cervical and breast cancer screening in Latin America and Caribbean: CanScreen5/CELAC project ( Dr Isabel Mosquera - International Agency for Research on Cancer, Lyon, France )
21 Nov 2022
Long-term breast cancer risk after benign breast disease in population-based...
Dr Marta Roman - Hospital del Mar Medical Research Institute, Barcelona, Spain
Long-term breast cancer risk after benign breast disease in population-based screening ( Dr Marta Roman - Hospital del Mar Medical Research Institute, Barcelona, Spain )
18 Nov 2022
Individualised breast cancer risk assessment model for BreastScreen Norway
Dr Javier Louro - Hospital del Mar Medical Research Institute, Barcelona, Spain.
Individualised breast cancer risk assessment model for BreastScreen Norway ( Dr Javier Louro - Hospital del Mar Medical Research Institute, Barcelona, Spain. )
17 Nov 2022
Molecular profiling in prostate cancer: key challenges for clinical...
Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain
Molecular profiling in prostate cancer: key challenges for clinical implementation ( Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain )
24 Oct 2022
Genomic testing: Australian model for unlocking the potential of precision...
Prof David Thomas - The Garvan Institute of Medical Research, Darlinghurst...
Genomic testing: Australian model for unlocking the potential of precision oncology for patients and health systems ( Prof David Thomas - The Garvan Institute of Medical Research, Darlinghurst, Australia )
21 Oct 2022
Intraoperative Radiotherapy
Dr Mahima Pant - National Academy for Medical Sciences (NAMS), Kathmandu, Nepal
Intraoperative Radiotherapy ( Dr Mahima Pant - National Academy for Medical Sciences (NAMS), Kathmandu, Nepal )
25 Sep 2022
ESMO 2022: Breast and ovarian trial analysis
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2022: Breast and ovarian trial analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
14 Sep 2022
ESMO 2022: Highlights, commentary and analysis
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2022: Highlights, commentary and analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
12 Sep 2022
Fruquintinib provides improvement in overall survival for refractory mCRC
Dr Nageshwara Arvind Dasari - MD Anderson Cancer Center, Houston, USA
Fruquintinib provides improvement in overall survival for refractory mCRC ( Dr Nageshwara Arvind Dasari - MD Anderson Cancer Center, Houston, USA )
12 Sep 2022
ESMO 2022: Breast cancer highlights
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
ESMO 2022: Breast cancer highlights ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
12 Sep 2022
Lenvatinib plus pembro for aRCC - update on the CLEAR study
Dr Bradley McGregor - Dana-Farber Cancer Institute, Boston, USA
Lenvatinib plus pembro for aRCC - update on the CLEAR study ( Dr Bradley McGregor - Dana-Farber Cancer Institute, Boston, USA )
12 Sep 2022
Abemaciclib plus NSAI for HR+, HER2- advanced breast cancer - MONARCH 3 interim...
Prof Matthew P Goetz - Mayo Clinic, Rochester, USA
Abemaciclib plus NSAI for HR+, HER2- advanced breast cancer - MONARCH 3 interim data ( Prof Matthew P Goetz - Mayo Clinic, Rochester, USA )
12 Sep 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation